DCs, clinical experts echo similar views in support of HCQ as COVID 19 drug with clarification of no cardiotoxicity in RA patients

pharmabiz.com – With hydroxychloroquine (HCQ) being preferred as the first line of treatment for COVID-19 patients and state drug controllers ensuring its adequate availability in the wake of rising COVID-19 cases, …



Source: HCQ News, DCs, clinical experts echo similar views in support of HCQ as COVID 19 drug with clarification of no cardiotoxicity in RA patients

Hydroxychloroquine Market to Garner $4.6 Billion, Globally, By 2027 at 7.9 % CAGR, Says Allied Market Research #HCQnews

markets.businessinsider.com – – Increase in demand for HCQ as a potential treatment option amidst the Covid-19 pandemic and surge in cases of malaria drive the growth of the global hydroxychloroquine market. PORTLAND, Ore., Sept.…



Source: HCQ News, Hydroxychloroquine Market to Garner .6 Billion, Globally, By 2027 at 7.9 % CAGR, Says Allied Market Research #HCQnews